Donor’s Immune Cells Could Help Transplant Recipients Avoid Organ Rejection
MONDAY, Oct. 16, 2023 (HealthDay News) — A liver transplant can give people a new lease on life, but at the cost of lifelong immune-suppressing medication and its risks. Now an innovative approach to reduce, or possibly eliminate, certain patients’ r…
Learn MorePressure Sores: What They Are, Causes, Stages, Symptoms & Treatment
Bedsores strike many of those who are largely confined to a bed or wheelchair, and they are tough to treat.Every year, over 2.5 million Americans suffer from pressure sores, also known as bedsores or pressure ulcers. These cause pain, raise the risk o…
Learn MoreSmall-Volume Blood Collection Tubes Could Cut RBC Transfusions
MONDAY, Oct. 16, 2023 (HealthDay News) — Use of small-volume blood collection tubes in the intensive care unit (ICU) may decrease red blood cell (RBC) transfusions, according to a study published online Oct. 12 in the Journal of the American Medical …
Learn MoreDriving Skills at Licensure Can Predict Crashes Early in Licensure
MONDAY, Oct. 16, 2023 (HealthDay News) — Driving skills measured at the time of licensure can predict crashes early in licensure, according to a study published online Oct. 16 in Pediatrics.Elizabeth A. Walshe, Ph.D., from the Children’s Hospital of …
Learn MoreCare Use, Financial Burden Increase Over Time for Elders With Dementia
MONDAY, Oct. 16, 2023 (HealthDay News) — For older adults, care use and financial burden increase substantially over time for those with dementia versus those without, according to a study published online Oct. 16 in JAMA Internal Medicine.HwaJung Ch…
Learn MoreIDSA: Maternal RSVpreF Vaccine Would Cut Clinical, Economic Burden
MONDAY, Oct. 16, 2023 (HealthDay News) — Maternal vaccination with a bivalent stabilized prefusion F subunit respiratory syncytial virus (RSV) vaccine (RSVpreF) is projected to reduce the clinical and economic burden of RSV lower respiratory tract il…
Learn MoreASTRO: Shorter Radiation Feasible for Low-, Intermediate-Risk Prostate Cancer
MONDAY, Oct. 16, 2023 (HealthDay News) — At five years, five-fraction stereotactic body radiotherapy (SBRT) is noninferior to control radiotherapy for biochemical/clinical failure (BCF) in men with localized prostate cancer (LPCa), according to a stu…
Learn More
English
Spanish